These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33892177)

  • 1. microRNAs and bone tumours: Role of tiny molecules in the development and progression of chondrosarcoma, of giant cell tumour of bone and of Ewing's sarcoma.
    Palmini G; Brandi ML
    Bone; 2021 Aug; 149():115968. PubMed ID: 33892177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA‑34b promotes proliferation, migration and invasion of Ewing's sarcoma cells by downregulating Notch1.
    Lu Q; Lu M; Li D; Zhang S
    Mol Med Rep; 2018 Oct; 18(4):3577-3588. PubMed ID: 30106161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?
    Palmini G; Marini F; Brandi ML
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28272374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression and its clinical implications in Ewing's sarcoma.
    Li Z; Yu X; Shen J; Wu WK; Chan MT
    Cell Prolif; 2015 Feb; 48(1):1-6. PubMed ID: 25530497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA and Bone Cancer.
    Nugent M
    Adv Exp Med Biol; 2015; 889():201-30. PubMed ID: 26659003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
    Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
    J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of the molecular genetic detection of the t(11;22) translocation in Ewing's tumours.
    Dockhorn-Dworniczak B; Schäfer KL; Dantcheva R; Blasius S; Winkelmann W; Strehl S; Burdach S; van Valen F; Jürgens H; Böcker W
    Virchows Arch; 1994; 425(2):107-12. PubMed ID: 7524975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MALIGNANT TUMOURS OF BONE.
    LAM SJ
    Nurs Times; 1964 Aug; 60():1072-5. PubMed ID: 14180282
    [No Abstract]   [Full Text] [Related]  

  • 9. Oncomeric Profiles of microRNAs as New Therapeutic Targets for Treatment of Ewing's Sarcoma: A Composite Review.
    Hassan M; Shahzadi S; Malik A; Din SU; Yasir M; Chun W; Kloczkowski A
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor expression as a biomarker of prognosis in patients with chondrosarcoma, Ewing's sarcoma and osteosarcoma. Current concepts.
    Capasso L; Florio M; Lillo M; Basilico M; De Santis V; Ziranu A; Grasso A; Minutillo F; Maccauro G
    J Biol Regul Homeost Agents; 2019; 33(2 Suppl. 1):39-43. . XIX Congresso Nazionale S.I.C.O.O.P. Societa' Italiana Chirurghi Ortopedici Dell'ospedalita' Privata Accreditata. PubMed ID: 31169001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
    Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
    Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
    Kinsey M; Smith R; Lessnick SL
    Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities.
    Burchill SA
    J Clin Pathol; 2003 Feb; 56(2):96-102. PubMed ID: 12560386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Biological Function of MicroRNAs in Bone Tumors.
    Scuderi SA; Calabrese G; Paterniti I; Campolo M; Lanza M; Capra AP; Pantaleo L; Munaò S; Colarossi L; Forte S; Cuzzocrea S; Esposito E
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathology of bone tumours: diagnostic implications.
    Puls F; Niblett AJ; Mangham DC
    Histopathology; 2014 Mar; 64(4):461-76. PubMed ID: 24428620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ewing's tumours, genetic and cellular aspects].
    Delattre O
    Pathol Biol (Paris); 2008 Jul; 56(5):257-9. PubMed ID: 18485618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.
    Nakatani F; Ferracin M; Manara MC; Ventura S; Del Monaco V; Ferrari S; Alberghini M; Grilli A; Knuutila S; Schaefer KL; Mattia G; Negrini M; Picci P; Serra M; Scotlandi K
    J Pathol; 2012 Apr; 226(5):796-805. PubMed ID: 21960059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ewing's Sarcoma: An Analysis of miRNA Expression Profiles and Target Genes in Paraffin-Embedded Primary Tumor Tissue.
    Parafioriti A; Bason C; Armiraglio E; Calciano L; Daolio PA; Berardocco M; Di Bernardo A; Colosimo A; Luksch R; Berardi AC
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27144561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma.
    Venneker S; Szuhai K; Hogendoorn PCW; Bovée JVMG
    Virchows Arch; 2020 Jan; 476(1):135-146. PubMed ID: 31728625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
    Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
    Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.